196 studies found for:    Open Studies | "Blood Platelet Disorders"
Show Display Options
Rank Status Study
21 Recruiting Caffeic Acid Combining High-dose Dexamethasone in Management of ITP
Condition: Immune Thrombocytopenia
Interventions: Drug: Caffeic acid tablets;   Drug: Dexamethasone;   Drug: placebo
22 Recruiting A Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura
Condition: Acquired Thrombotic Thrombocytopenic Purpura
Interventions: Biological: caplacizumab;   Biological: placebo
23 Recruiting Study of Voncento® in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Voncento
24 Recruiting Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2
Condition: Heparin-induced Thrombocytopenia
Intervention: Procedure: Blood Draw
25 Not yet recruiting Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)
Conditions: Primary Myelofibrosis (PMF);   Post-polycythemia Vera (Post-PV) Myelofibrosis;   Postessential Thrombocythemia (Post-ET) Myelofibrosis
Intervention: Drug: MMB
26 Not yet recruiting Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
Conditions: Aneurysmal Subarachnoid Hemorrhage;   Neurobehavioral Manifestations;   Vasospasm, Intracranial;   Intracranial Aneurysm;   Heparin-induced Thrombocytopenia Type II
Intervention: Drug: Continuous Low-Dose Intravenous Unfractionated Heparin Infusion (14 days)
27 Not yet recruiting Prospective Study of Patients With Thrombocytopenia Following HSCT
Conditions: Thrombocytopenia;   Hematologic Diseases
Interventions: Drug: decitabine;   Drug: rhTPO
28 Recruiting Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: plasma-derived FVIII/VWF concentrate Fanhdi
29 Not yet recruiting Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)
Condition: Von Willebrands Disease
30 Recruiting Complement Inhibition in aHUS Dialysis Patients
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: CCX168
31 Not yet recruiting Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE
Condition: Thrombocytopenia
Interventions: Drug: Hydroxychloroquine;   Drug: Cyclophosphamide;   Drug: Azathioprine;   Drug: Methylprednisolone
32 Recruiting Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Therapy for Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis With Progressive or Relapsed Disease
Condition: Myelofibrosis
Interventions: Drug: Idelalisib;   Drug: Ruxolitinib
33 Recruiting Study of Nivolumab in Patients With Myelofibrosis
Condition: Myeloproliferative Diseases
Interventions: Drug: Nivolumab;   Behavioral: Questionnaire;   Behavioral: Phone Call
34 Recruiting Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia
Conditions: Polycythemia Vera;   Essential Thrombocythemia
Interventions: Drug: RG7388;   Drug: Pegasys
35 Recruiting A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Hetrombopag Olamine
36 Not yet recruiting Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia
Condition: Primacy Immune Thrombocytopenia
Intervention: Drug: Eltrombopag
37 Recruiting Open-Label, Dose Escalation Study of PRTX-100 in Adults With Persistent/Chronic Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: PRTX-100
38 Recruiting Lymphatic Anomalies Registry
Conditions: Lymphatic Malformation;   Generalized Lymphatic Anomaly (GLA);   Central Conducting Lymphatic Anomaly;   CLOVES Syndrome;   Gorham-Stout Disease ("Disappearing Bone Disease");   Blue Rubber Bleb Nevus Syndrome;   Kaposiform Lymphangiomatosis;   Kaposiform Hemangioendothelioma/Tufted Angioma;   Klippel-Trenaunay Syndrome;   Lymphangiomatosis
39 Recruiting A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy
Conditions: Immune Thrombocytopenia;   Pregnancy
Intervention: Drug: rhTPO
40 Recruiting Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
Conditions: Chronic Liver Disease;   Thrombocytopenia
Interventions: Drug: Lusutrombopag;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years